Vasculitis Flashcards

(45 cards)

1
Q

Define vasculitis?

A

Inflammation of blood vessels, often with ischaemia and necrosis, thrombosis and organ inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Areas affected by vasculitis?

A

Any blood vessel, inc. capillaries

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Define primary and secondary vasculitis?

A

Primary: results from an inflammatory response that targets the vessel walls and has an UNKNOWN CAUSE; it is sometimes autoimmune

Secondary: may be triggered by an infection, drug, toxin or it may occur as part of another inflammatory disorder of cancer, e.g: paraneoplastic vasculitis assoc. with cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Pathophysiology of vasculitis?

A
  1. Activated dendritic cells release cytokines that activate T cells and cause vascular inflammation
  2. T cells promote inflammation, GRANULOMA formation and macrophage activation
  3. Macrophages release mediators that cause progressive vascular inflammation, endothelial damage and intimal hyperplasia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Main classifications of vaculitis?

A

Large-vessel, inc. Takayasu arteritis and giant cell arteritis

Medium-vessel, inc. polyarteritis nodosa and Kawasaki disease

Small-vessel is split into two categories

PICTURE 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

2 categories of small vessel vasculitis?

A

ANCA-associated small-vessel vasculitis (AAV):
• Granulomatosis with polyangiitis (GPA)
• Eosinophilic granulomatosis with polyangiitis (EGPA)
• Microscopic polyangiitis (MPA)

Immune complex small-vessel vasculitis:
• Henoch-Schönlein (common)
• Others

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Systemic symptoms common to all vasculitides?

A

Fever
Malaise
Fatigue
Weight loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Two main causes of large vessel vasculitis and histopathology?

A

Takayasu arteritis (TA)

Giant Cell arteritis (GCA)

There is GRANULOMATOUS infiltration of the large vessel walls

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Occurrence of takayasu arteritis?

A

Tends to affect those <40 YEARS

More common in FEMALES

It is much more prevalent in Asian populations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Occurrence of GCA?

A

Generally affects those > 50 YEARS

Typically causes temporal arteritis but the aorta and other large vessels may be affected

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Signs on examination of large vessel vasculitis?

A
  • Bruit (usually if carotid artery is affected)
  • BP difference of extremities
  • Claudication (in Takayasu, this occurs suspiciously in younger people)
  • Carotydinia or vessel tenderness (painful to touch)
  • Hypertension
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Occurrence of temporal arteritis?

A

Assoc. with polymyalgia rheumatica

About 50% with GCA have PMR, and about 15% of individuals with PMR develop GCA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Classical symptoms of temporal arteritis?

A
  • Unilateral temporal headache
  • Scalp tenderness
  • Jaw claudication
  • Prominent temporal arteries with reduced pulsation
  • Pain over temporal artery
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Risks with temporal arteritis?

A

Of blindness due to ischaemia of the optic nerve

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Ix of temporal arteritis?

A

Inflammatory markers (ESR, PV and CRP) are raised

Temporal artery biopsy shows granulomas; biopsy may be -ve as there are SKIP LESIONS

MR angiogram can show stenosis/thickening/aneurysm

PET CT can shows increased metabolic activity of inflammatory cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Management of temporal arteritis?

A

If there are no visual problems, 40 mg prednisolone gradually reduced over 18 months to 2 years

If there are visual problems, 60 mg prednisolone gradually reduced over 18 months to 2 years

Occasionally, if the patient struggles with a reduced steroid dose, methotrexate/azathioprine may be considered

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Types of medium vessel vasculitis?

A

Kawasaki disease

Polyarteritis nodosa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is Kawasaki disease?

A

Seen in CHILDREN, usually < 5 years, often following an INFECTION

Causes vasculitis of various vessels but can affect CORONARY ARTERIES, leading to aneurysm development

Tends to be self-limiting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is polyarteritis nodosa?

A

Characterised by necrotising inflammatory lesions that affect arteries at vessel bifurcations, leading to microaneurysm and aneurym formation, and often affecting skin, gut and kidneys

Assoc. with HEP B

20
Q

What were the different types of small vessel vaculitis previously known as?

A

GPA was previously known as Wegener’s granulomatosis

EGPA was previously known as Churg-Strauss syndrome

Microscopic polyangiitis has not changed name

21
Q

Pathology of GPA?

A

Granulomatous inflammation of respiratory tract, small and medium vessels

Necrotising GLOMERULONEPHRITIS common

22
Q

Pathology of EGPA?

A

Eosinophilic granulomatous inflammation of respiratory tract, small and medium vessels; increased eosinophils in blood and tissues

Assoc. with asthma

23
Q

Pathology of MPA?

A

Necrotising vasculitis with few immune deposits

Necrotising GLOMERULONEPHRITIS very common

24
Q

Ecologic factors in development of AAV?

A

Bacteria - Staph. aureus carriage in the nose increases risk of GPA

Genetic factors

Environmental, e.g: silica

Drugs, e.g: hydralazine

25
Occurrence of GPA?
More common in northern european descent SLIGHTLY MORE COMMON in MALES Can occur at any age, usually between 35-55 years
26
GPA classification critera?
Must have at least 2 of the 4 criteria
27
ENT features of GPA?
There are the cardinal features: • Sinusitis (stuffiness and discharge) • Nasal crusting • Epistaxis (nosebleed) • Mouth ulcers * Sensorineural deafness * Otitis media (infection of middle ear) and deafness • "Saddle nose" due to cartilage ischaemia
28
Respiratory signs of GPA?
Cough and haemoptysis Diffuse alveolar hemorrhage (emergency) ``` Pulmonary infiltrates Cavitating nodules (usually, > 1) on CXR ```
29
Cutaneous signs of GPA?
NON-BLANCHING, raised/palpable purpura These can join together and ulcerate
30
Renal issues in GPA?
NECROTISING GLOMERULONEPHRITIS manifests as blood and protein in the urine
31
Nervous system manifestations of GPA?
Mononeuritis multiplex commonly presents with wrist/foot drop Sensorimotor polyneuropathy Cranial nerve palsies (cannot move eye either due to granuloma invasion of a muscle or ischaemia of the nerve)
32
Ocular manifestations of GPA?
* Conjunctivitis, episcleritis, uveitis * Optic nerve vasculitis * Retinal artery occlusion * Proptosis (eye is pushed outwards by a large granuloma)
33
Main differences between GPA and EGPA?
Late onset asthma High eosinophil count It does not have the same ENT signs that GPA does, e.g: nasal cartilage, collapse is not common
34
Criteria for EGPA?
Should have 4 or more of: • Asthma (wheezing, expiratory rhonchi) * Eosinophilia * Paranasal sinusitis * Pulmonary infiltrates (may be transient) * Histological proof of vasculitis with extravascular eosinophils * Mononeuritis multiplex or polyneuropathy
35
What is ANCA?
Anti-neutrophil cytoplasmic antibodies - group of antibodies in the cytoplasm of neutrophil grnaulocytes
36
Types of ANCA?
cANCA (cytoplasmic) is very specific to GPA pANCA (perinuclear) is less specific and are present in MPA and EGPA
37
Other antibodies?
Anti-PR3 is very specific for GPA Anti-MPO is seen in EGPA and MPA; it is not as useful for GPA
38
Antibodies present in GPA?
cANCA and anti-PR3
39
Antibodies present in EGPA?
pANCA and anti-MPO
40
How can disease be monitored?
ANCA, anti-PR3 and anti-MPO levels all vary with disease activity Complement is consumed during active disease so C3/4 may fall
41
Management of AAV?
Localised/early systemic: • Methotrexate + steroids Generalised/systemic: • 1st line - CYCLOPHOSPHAMIDE + STEROIDS • Alternative - Rituximab + steroids • This is followed by azathioprine; alternative inc. methotrexate, etc Refractory (severe): • IV Ig • Rituximab
42
What is Henoch-Schönlein purpura (HSP)?
AKA acute IgA mediated disorder; it is a type of immune complex small-vessel vasculitis that tends to occur in CHILDREN between 2-11 YEARS (RARE in INFANTS) It is a generalised vasculitis inv. small vessels of the skin, GI tract, kidneys and joints; rarely, vessel of the lungs and CNS
43
Triggers of HSP?
Most have a preceding URT, pharyngeal or GI infection. which usually occurs 1-3 weeks beforehand Most common is group A Strep.
44
Presentation of HSP?
Purpuric rash typically over buttocks and lower limbs, sparing the upper body Colicky abdominal pain Bloody diarrhoea Joint pain +/- swelling Renal involvement (50%)
45
Management of HSP?
Usually, SELF-LIMITING and symptoms tend to resolve within 8 weeks; relapses may occur for months-years but will eventually stop MUST PERFORM URINALYSIS to screen for renal inv.